These findings align with a previous study where decreased miR-204-5p levels were observed in CSF exosomes from presymptomatic C9ORF72, MAPT, and GRN carriers, suggesting that miR-204-5p could serve as a biomarker for early detection of FTD pathology [43]. The gene discussed is MAPT; the disease is frontotemporal dementia.